In this study, we prepared Fe3O4 nanoparticles and design siRNAs targeting BCL2 and BIRC5, aiming to explore the efficient delivery of therapeutic siRNA into oral cancer cells by Fe3O4 nanoparticles, which might provide a novel strategy for the future therapy of oral cancer. This evidence concerns the gene BCL2 and lip and oral cavity carcinoma.